Antimicrobial photodynamic therapy
(aPDT) has emerged as a novel
and promising approach for the treatment of pathogenic microorganism
infections. The efficacy of aPDT depends greatly on the behavior of
the photosensitizer. Herein, we report the design, preparation, antimicrobial
photodynamic activities, as well as structure–activity relationships
of a series of photosensitizers modified at the meso position of a 1,3,5,7-tetramethyl BODIPY scaffold with various pyridinyl
and pyridinium moieties. The photodynamic antimicrobial activities
of all photosensitizers have been tested against Staphylococcus
aureus, Escherichia coli, Candida albicans, and Methicillin-resistant S. aureus (MRSA). The methyl meso-(meta-pyridinium) BODIPY photosensitizer (3c) possessed the highest phototoxicity against these pathogens
at minimal inhibitory concentrations (MIC) ranging from 0.63 to 1.25
μM with a light dose of 81 J/cm2. Furthermore, 3c exhibited an impressive antimicrobial efficacy in S. aureus-infected mice wounds. Taken together, these
findings suggest that 3c is a promising candidate as
the antimicrobial photosensitizer for combating pathogenic microorganism
infections.